131 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
Pharma’s team has delivered innovative treatments to rare disease patients with high unmet medical needs. By joining forces and expertise we will be able … Global Rare Diseases
Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
2023.
About Amryt
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those … -stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments to help improve the lives of patients
6-K
EX-99.5
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio
6-K
EX-99.3
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
#.
About AmrytAmryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments
6-K
EX-99.4
hv3nvjadaz 03ge
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
wxu67a97t7x8jr
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.2
wcsm7q
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.7
wsgr8b98dv
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.4
58sgw15n
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.2
bufmpwyj
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
wql zfkhf
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.5
zvhaugcp5noio y61c
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
hz9qmyydqwzw
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
xgwaf2
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.4
dna j74j5eoq4
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.2
53uwg fzzn03wi67
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.3
4srdb
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
ex1cbq3
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
EX-99.1
nxk5i4
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am